<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Publisher PUBLIC "-//Springer-Verlag//DTD A++ V2.4//EN" "http://devel.springer.de/A++/V2.4/DTD/A++V2.4.dtd">
<Publisher>
  <PublisherInfo>
    <PublisherName>Humana Press</PublisherName>
    <PublisherLocation>Totowa, NJ</PublisherLocation>
  </PublisherInfo>
  <Series>
    <SeriesInfo SeriesType="Series" TocLevels="0">
      <SeriesID>7651</SeriesID>
      <SeriesPrintISSN>1064-3745</SeriesPrintISSN>
      <SeriesElectronicISSN>1940-6029</SeriesElectronicISSN>
      <SeriesTitle Language="En">Methods in Molecular Biology™</SeriesTitle>
    </SeriesInfo>
    <SeriesHeader>
      <EditorGroup>
        <Editor AffiliationIDS="Aff1">
          <EditorName DisplayOrder="Western">
            <GivenName>J.M.</GivenName>
            <FamilyName>Walker</FamilyName>
          </EditorName>
        </Editor>
        <Affiliation ID="Aff1">
          <OrgName>School of Life Sciences University of Hertfordshire</OrgName>
          <OrgAddress>
            <City>Hatfield</City>
            <State>Hertfordshire, AL10 9AB</State>
            <Country>UK</Country>
          </OrgAddress>
        </Affiliation>
      </EditorGroup>
    </SeriesHeader>
    <Book Language="En">
      <BookInfo BookProductType="Contributed volume" ContainsESM="No" Language="En" MediaType="eBook" NumberingStyle="ChapterContentSeparately" OutputMedium="Online" TocLevels="0">
        <BookID>978-1-60327-527-9</BookID>
        <BookTitle>T Cell Protocols</BookTitle>
        <BookSubTitle>Second Edition</BookSubTitle>
        <BookVolumeNumber>514</BookVolumeNumber>
        <BookSequenceNumber>514</BookSequenceNumber>
        <BookDOI>10.1007/978-1-60327-527-9</BookDOI>
        <BookTitleID>145011</BookTitleID>
        <BookPrintISBN>978-1-58829-587-3</BookPrintISBN>
        <BookElectronicISBN>978-1-60327-527-9</BookElectronicISBN>
        <BookChapterCount>11</BookChapterCount>
        <BookCopyright>
          <CopyrightHolderName>Humana Press</CopyrightHolderName>
          <CopyrightYear>2009</CopyrightYear>
        </BookCopyright>
        <BookSubjectGroup>
          <BookSubject Code="SCL" Type="Primary">Life Sciences</BookSubject>
          <BookSubject Code="SCL14005" Priority="1" Type="Secondary">Biochemistry, general</BookSubject>
          <BookSubject Code="SCB14000" Priority="2" Type="Secondary">Immunology</BookSubject>
          <BookSubject Code="SCL16020" Priority="3" Type="Secondary">Cell Culture</BookSubject>
          <SubjectCollection Code="SUCO11642">Biomedical and Life Sciences</SubjectCollection>
        </BookSubjectGroup>
        <BookContext>
          <SeriesID>7651</SeriesID>
        </BookContext>
      </BookInfo>
      <BookHeader>
        <EditorGroup>
          <Editor AffiliationIDS="Aff2">
            <EditorName DisplayOrder="Western">
              <GivenName>Gennaro</GivenName>
              <Particle>De</Particle>
              <FamilyName>Libero</FamilyName>
            </EditorName>
            <Role>Dr</Role>
            <Contact>
              <Email>Gennaro.DeLibero@unibas.ch</Email>
            </Contact>
          </Editor>
          <Affiliation ID="Aff2">
            <OrgName>University of Basel</OrgName>
            <OrgAddress>
              <State>Basel</State>
              <Country>Switzerland</Country>
            </OrgAddress>
          </Affiliation>
        </EditorGroup>
      </BookHeader>
      <Chapter ID="Chap8" Language="En">
        <ChapterInfo ChapterType="OriginalPaper" ContainsESM="No" Language="En" NumberingStyle="ChapterContentSeparately" OutputMedium="Online" TocLevels="0">
          <ChapterID>8</ChapterID>
          <ChapterNumber>Chapter 8</ChapterNumber>
          <ChapterDOI>10.1007/978-1-60327-527-9_8</ChapterDOI>
          <ChapterSequenceNumber>8</ChapterSequenceNumber>
          <ChapterTitle Language="En">T Cell Epitope-Mapping by Cytokine Gene Expression Assay</ChapterTitle>
          <ChapterFirstPage>107</ChapterFirstPage>
          <ChapterLastPage>118</ChapterLastPage>
          <ChapterCopyright>
            <CopyrightHolderName>Humana Press, a part of Springer Science+Business Media, LLC</CopyrightHolderName>
            <CopyrightYear>2009</CopyrightYear>
          </ChapterCopyright>
          <ChapterGrants Type="Regular">
            <MetadataGrant Grant="OpenAccess"/>
            <AbstractGrant Grant="OpenAccess"/>
            <BodyPDFGrant Grant="Restricted"/>
            <BodyHTMLGrant Grant="Restricted"/>
            <BibliographyGrant Grant="Restricted"/>
            <ESMGrant Grant="Restricted"/>
          </ChapterGrants>
          <ChapterContext>
            <SeriesID>7651</SeriesID>
            <BookID>978-1-60327-527-9</BookID>
            <BookTitle>T Cell Protocols</BookTitle>
          </ChapterContext>
        </ChapterInfo>
        <ChapterHeader>
          <AuthorGroup>
            <Author AffiliationIDS="Aff3" CorrespondingAffiliationID="Aff3">
              <AuthorName DisplayOrder="Western">
                <GivenName>Maurizio</GivenName>
                <FamilyName>Provenzano</FamilyName>
              </AuthorName>
              <Role>MD</Role>
            </Author>
            <Author AffiliationIDS="Aff4">
              <AuthorName DisplayOrder="Western">
                <GivenName>Giulio</GivenName>
                <GivenName>C.</GivenName>
                <FamilyName>Spagnoli</FamilyName>
              </AuthorName>
              <Role>MD</Role>
            </Author>
            <Affiliation ID="Aff3">
              <OrgDivision>Department of Urology</OrgDivision>
              <OrgName>University Hospital of Zurich</OrgName>
              <OrgAddress>
                <State>Zurich</State>
                <Country>Switzerland</Country>
              </OrgAddress>
            </Affiliation>
            <Affiliation ID="Aff4">
              <OrgName>Institute of Surgical Research and Hospital Management, University Hospital Basel</OrgName>
              <OrgAddress>
                <State>Basel</State>
                <Country>Switzerland</Country>
              </OrgAddress>
            </Affiliation>
          </AuthorGroup>
          <Abstract ID="Abs1" Language="En">
            <Heading>Abstract</Heading>
            <Para TextBreak="No">The following method describes the identification of candidate immunogenic peptides through their ability to recall an immune T-cell activation from peripheral blood mononuclear cells (PBMCs) of individuals with defined HLA–peptide restrictions that have been previously exposed to the antigen. Isolated PBMCs are plated out at a concentration of 1×10<Superscript>6</Superscript> cells/ml in a 200 μl medium and incubated overnight to reduce cytokine gene expression due to cell manipulation. After starving, cells are either directly stimulated with individual peptides or not stimulated and incubated from 3 to 12 h according to experimental conditions. Quantitative real-time PCR (qrt-PCR) is performed on reverse-transcribed complementary DNA (cDNA) from total RNA that is isolated from peptide-cultured PBMCs. To perform high quality qrt-PCR, primers and probes are designed to span exon–intron junctions in order to prevent amplification of genomic DNA and to produce amplicons &lt;150 base pairs (bp). Real-time monitoring of fluorescent emission from the cleavage of sequence specific probe by the nuclease activity of <Emphasis Type="Italic">Taq</Emphasis> polymerase (TaqMan method) defines threshold cycles during exponential phases of amplification. Standard curves of copy numbers of the gene of interest are normalized using as reference copy numbers of control genes.</Para>
          </Abstract>
          <KeywordGroup Language="En">
            <Heading>Key words</Heading>
            <Keyword>Quantitative real-time PCR</Keyword>
            <Keyword>T cell</Keyword>
            <Keyword>epitope mapping</Keyword>
          </KeywordGroup>
        </ChapterHeader>
        <Body>
          <Section1 ID="Sec1" OutputMedium="Online" Type="Introduction">
            <Heading>Introduction</Heading>
            <Para TextBreak="No">This method is based on the ability of peptides to recall an immune T-cell activation. Levels of cytokine gene expression in response to ex vivo antigen recall are used to detect epitope-specific HLA-restricted T cells. The main rationale for using ex vivo techniques is based on the notion that PBMCs that bear HLA determinants relevant to the HLA–peptide restriction under investigation carry memory T cells that have been exposed in vivo to the antigen of interest, either naturally upon viral infection <CitationRef CitationID="CR1">(1)</CitationRef> or following specific vaccination procedures <CitationRef CitationID="CR2">(2)</CitationRef>. Thus, this sensitive assay might be able to identify these responses without in vitro cell expansion. The stronger the immune response induced in vivo against epitopes from the selected antigen, the easier and more specific should be the detection of memory T-cell activities. The magnitude of cytokine gene transcription upon peptide stimulation, as analyzed by qrt-PCR in serologically positive donors, represents an accurate index of the biological events following T-cell reactivation triggered by specific MHC–peptide complexes <CitationRef CitationID="CR3">(3)</CitationRef>. The sensitivity and specificity of this method are decisive in unravelling the fine relationship between MHC–peptide associations and specific immune responses, enabling the characterization of more than one HLA restriction for one individual epitope.</Para>
          </Section1>
          <Section1 ID="Sec2" OutputMedium="Online">
            <Heading>Materials</Heading>
            <Para TextBreak="No">
              <OrderedList>
                <ListItem>
                  <ItemNumber>1.</ItemNumber>
                  <ItemContent>
                    <Para TextBreak="No">Ficoll–Hypaque density gradient</Para>
                  </ItemContent>
                </ListItem>
                <ListItem>
                  <ItemNumber>2.</ItemNumber>
                  <ItemContent>
                    <Para TextBreak="No">Phosphate Buffered Saline (PBS)</Para>
                  </ItemContent>
                </ListItem>
                <ListItem>
                  <ItemNumber>3.</ItemNumber>
                  <ItemContent>
                    <Para TextBreak="No">RPMI-1640 cell culture medium supplemented with 100 μg/mL Kanamycin, 10 mM Hepes, 1 mM sodium pyruvate, 1 mM Glutamax, non-essential amino acids, and 5% human serum (thereafter referred to as complete medium).</Para>
                  </ItemContent>
                </ListItem>
                <ListItem>
                  <ItemNumber>4.</ItemNumber>
                  <ItemContent>
                    <Para TextBreak="No">RNeasy Mini Kit (QIAGEN)</Para>
                  </ItemContent>
                </ListItem>
                <ListItem>
                  <ItemNumber>5.</ItemNumber>
                  <ItemContent>
                    <Para TextBreak="No">β-Mercaptoethanol (β-ME), 14.3 M</Para>
                  </ItemContent>
                </ListItem>
                <ListItem>
                  <ItemNumber>6.</ItemNumber>
                  <ItemContent>
                    <Para TextBreak="No">Ethanol (96–100%)</Para>
                  </ItemContent>
                </ListItem>
                <ListItem>
                  <ItemNumber>7.</ItemNumber>
                  <ItemContent>
                    <Para TextBreak="No">DEPC water (0.1% diethylpyrocarbonate-treated water)</Para>
                  </ItemContent>
                </ListItem>
                <ListItem>
                  <ItemNumber>8.</ItemNumber>
                  <ItemContent>
                    <Para TextBreak="No">1× TE solution: 1 mM Tris–HCl, 0.1 mM EDTA, pH 8.0</Para>
                  </ItemContent>
                </ListItem>
                <ListItem>
                  <ItemNumber>9.</ItemNumber>
                  <ItemContent>
                    <Para TextBreak="No">Oligo dT primers (0.5 μg/μl)</Para>
                  </ItemContent>
                </ListItem>
                <ListItem>
                  <ItemNumber>10.</ItemNumber>
                  <ItemContent>
                    <Para TextBreak="No">RT buffer 10×</Para>
                  </ItemContent>
                </ListItem>
                <ListItem>
                  <ItemNumber>11.</ItemNumber>
                  <ItemContent>
                    <Para TextBreak="No">MgCl<Subscript>2</Subscript> (25 mmol)</Para>
                  </ItemContent>
                </ListItem>
                <ListItem>
                  <ItemNumber>12.</ItemNumber>
                  <ItemContent>
                    <Para TextBreak="No">dNTP 10 mmol</Para>
                  </ItemContent>
                </ListItem>
                <ListItem>
                  <ItemNumber>13.</ItemNumber>
                  <ItemContent>
                    <Para TextBreak="No">DTT (1 M)</Para>
                  </ItemContent>
                </ListItem>
                <ListItem>
                  <ItemNumber>14.</ItemNumber>
                  <ItemContent>
                    <Para TextBreak="No">Superscript RT II (50 U/μl) (Invitrogen)</Para>
                  </ItemContent>
                </ListItem>
                <ListItem>
                  <ItemNumber>15.</ItemNumber>
                  <ItemContent>
                    <Para TextBreak="No">RNase</Para>
                  </ItemContent>
                </ListItem>
                <ListItem>
                  <ItemNumber>16.</ItemNumber>
                  <ItemContent>
                    <Para TextBreak="No">HotStart mix (QIAGEN)</Para>
                  </ItemContent>
                </ListItem>
                <ListItem>
                  <ItemNumber>17.</ItemNumber>
                  <ItemContent>
                    <Para TextBreak="No">Forward primers</Para>
                  </ItemContent>
                </ListItem>
                <ListItem>
                  <ItemNumber>18.</ItemNumber>
                  <ItemContent>
                    <Para TextBreak="No">Reverse primers</Para>
                  </ItemContent>
                </ListItem>
                <ListItem>
                  <ItemNumber>19.</ItemNumber>
                  <ItemContent>
                    <Para TextBreak="No">Fluorogenic probes</Para>
                  </ItemContent>
                </ListItem>
                <ListItem>
                  <ItemNumber>20.</ItemNumber>
                  <ItemContent>
                    <Para TextBreak="No">1× TaqMan Universal Master Mix<Superscript>®</Superscript> (Applied Biosystems, AB)</Para>
                  </ItemContent>
                </ListItem>
              </OrderedList>
            </Para>
          </Section1>
          <Section1 ID="Sec3" OutputMedium="Online">
            <Heading>Methods</Heading>
            <Para TextBreak="No">The methods described below outline: (1) Cell collection and culture and peptide handling, (2) RNA extraction and complementary DNA (cDNA) synthesis, (3) design of primers and probes for quantitative rt-PCR (qrt-PCR) and their reconstitution, 4) quantitative rt-PCR performance.</Para>
            <Section2 ID="Sec4" OutputMedium="Online">
              <Heading>Cells and Peptides</Heading>
              <Para TextBreak="No">Collection, culture and handling of the cells and peptide design and reconstitution are described in <Emphasis Type="Bold">Sects. 3.1.1–3.1.3</Emphasis>.</Para>
              <Section3 ID="Sec5" OutputMedium="Online">
                <Heading>Ficoll–Hypaque Density Gradient</Heading>
                <Para TextBreak="No">
                  <OrderedList>
                    <ListItem>
                      <ItemNumber>1.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">Whole blood from either healthy donors or patients is collected in 7 ml heparinized tubes (Sarstedt) by venipuncture.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>2.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">Transfer 10 ml of whole blood into a 50 ml Falcon tube and add 30 ml PBS to reach a total of 40 ml (<Emphasis Type="Bold">Fig.</Emphasis>
                          <InternalRef RefID="Fig8_1_978-1-60327-527-9">
                            <Emphasis Type="Bold">8.1</Emphasis>
                          </InternalRef>
                          <Emphasis Type="Bold">a</Emphasis>).<Figure Category="Standard" Float="Yes" ID="Fig8_1_978-1-60327-527-9">
                            <Caption Language="En">
                              <CaptionNumber>Fig. 8.1.</CaptionNumber>
                              <CaptionContent>
                                <SimplePara>Ficoll–Hypaque density gradient. (<Emphasis Type="Bold">a</Emphasis>) Transfer 10 ml of whole blood into a 50 ml Falcon tube and add 30 ml PBS to reach 40 ml total. (<Emphasis Type="Bold">b</Emphasis>) Mix well by shaking. (<Emphasis Type="Bold">c</Emphasis>) Introduce 10 ml pipette containing Ficoll fluid and flow fluid slowly from the bottom of the tube. (<Emphasis Type="Bold">d</Emphasis>) Centrifuge and aspirate the leukocyte ring and the 5 ml fluid (serum) overlaying the gradient interface.</SimplePara>
                              </CaptionContent>
                            </Caption>
                            <MediaObject>
                              <ImageObject Color="BlackWhite" FileRef="MediaObjects/978-1-60327-527-9_8_Fig1_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Linedraw"/>
                            </MediaObject>
                          </Figure>
                        </Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>3.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">Mix well by shaking and then add 10 ml Ficoll–Hypaque by introducing a 10 ml pipette containing Ficoll fluid (<Emphasis Type="Bold">Fig.</Emphasis>
                          <InternalRef RefID="Fig8_1_978-1-60327-527-9">
                            <Emphasis Type="Bold">8.1b</Emphasis>
                          </InternalRef>
                          <Emphasis Type="Bold">and c</Emphasis>).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>4.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">Flow Ficoll fluid slowly from the bottom of the tube (<Emphasis Type="Bold">Fig.</Emphasis>
                          <InternalRef RefID="Fig8_1_978-1-60327-527-9">
                            <Emphasis Type="Bold">8.1c</Emphasis>
                          </InternalRef>).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>5.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">Centrifuge at 1,950 rpm for 20 min at 20°C without brake.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>6.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">Discard by aspirating the fluid overlaying the gradient interface (serum) leaving at least 5 ml of it over the leukocyte ring (<Emphasis Type="Bold">Fig.</Emphasis>
                          <InternalRef RefID="Fig8_1_978-1-60327-527-9">
                            <Emphasis Type="Bold">8.1d</Emphasis>
                          </InternalRef>).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>7.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">Aspirate the leukocyte ring with a 10 ml pipette carefully avoiding collecting the underlaying Ficoll fluid (toxic for cells).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>8.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">Transfer the cells in a new 50 ml Falcon tube and fill it up to 50 ml with PBS. Mix well.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>9.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">Centrifuge at 1,250 rpm for 15 min (long-wash) at 20°C, discard the supernatant and re-suspend the pellet in fresh PBS (50 ml total).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>10.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">Repeat the washing at 1,250 rpm for 10 min (short wash) at 20°C.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>11.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">Re-suspend cells (PBMCs) in RPMI complete medium (<Emphasis Type="Italic">see</Emphasis>
                          <Emphasis Type="Bold">Section</Emphasis>
                          <Emphasis Type="Bold">2</Emphasis>), count them and adjust them at 1×10<Superscript>6</Superscript>cells/ml.</Para>
                      </ItemContent>
                    </ListItem>
                  </OrderedList>
                </Para>
              </Section3>
              <Section3 ID="Sec6" OutputMedium="Online">
                <Heading>Peptide Synthesis, Reconstitution, and Storage</Heading>
                <Para TextBreak="No">Peptides in powder are reconstituted in a DMSO solution ranging from 20 to 100% depending on the solubility of the peptides. Reconstituted peptides are generally stocked in 1.5 ml cryo-vials and stored at +4°C during their use or stored at –20°C for long term storage. Peptide-stocks at 10 mg/ml concentrations are usually preferred.</Para>
              </Section3>
              <Section3 ID="Sec7" OutputMedium="Online">
                <Heading>PBMCs Plating, Culturing, and Harvesting</Heading>
                <Para TextBreak="No">
                  <OrderedList>
                    <ListItem>
                      <ItemNumber>1.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">PBMCs re-suspended in RPMI complete medium at the final concentration of 1×10<Superscript>6</Superscript>cells/ml are now plated out in 96-U bottom wells plate.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>2.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">A total amount of 200 μl RPMI medium (2×10<Superscript>5</Superscript> cells total) is plated in each well.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>3.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">The number of total loaded wells will depend on the sample condition (number of peptides) you wish to analyze plus eventual positive controls (at least one) and the negative control (cells left unstimulated) (<Emphasis Type="Bold">Fig.</Emphasis>
                          <InternalRef RefID="Fig8_2_978-1-60327-527-9">
                            <Emphasis Type="Bold">8.2</Emphasis>
                          </InternalRef>
                          <Emphasis Type="Bold">a</Emphasis>).<Figure Category="Standard" Float="Yes" ID="Fig8_2_978-1-60327-527-9">
                            <Caption Language="En">
                              <CaptionNumber>Fig. 8.2.</CaptionNumber>
                              <CaptionContent>
                                <SimplePara>(<Emphasis Type="Bold">a</Emphasis>) Plate out PBMCs in 96-U bottom wells plate at the final amount of 2×10<Superscript>5</Superscript>cells total (200 μl RPMI medium). Rest plated cells over-night in incubator (37°C, 5% CO<Subscript>2</Subscript>, 90% humidity) to minimize cytokine gene expression. (<Emphasis Type="Bold">b</Emphasis>) After starving, add directly in the well the candidate peptide at the final concentration of 1 μM. Re-incubate cells for 3 h. (<Emphasis Type="Bold">c</Emphasis>) Harvest cells transferring them in collection tubes.</SimplePara>
                              </CaptionContent>
                            </Caption>
                            <MediaObject>
                              <ImageObject Color="BlackWhite" FileRef="MediaObjects/978-1-60327-527-9_8_Fig2_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Linedraw"/>
                            </MediaObject>
                          </Figure>
                        </Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>4.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">After plating, cells are rested for 18 h (normally over-night resting) in incubator (37°C, 5% CO<Subscript>2</Subscript>, 90% humidity) to minimize cytokine gene expression due to cell manipulation.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>5.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">After resting, cells are directly stimulated with each of the candidate peptide (plus control) at the final concentration of 1 μM peptide or left unstimulated (DMSO solution only; negative control) (<Emphasis Type="Bold">Fig.</Emphasis>
                          <InternalRef RefID="Fig8_2_978-1-60327-527-9">
                            <Emphasis Type="Bold">8.2b</Emphasis>
                          </InternalRef>).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>6.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">Cells are then re-incubated (37°C, 5% CO<Subscript>2</Subscript>, 90% humidity) for an extra 3-h period (<Emphasis Type="Italic">see</Emphasis>
                          <Emphasis Type="Bold">Note</Emphasis>
                          <Emphasis Type="Bold">1</Emphasis>).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>7.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">Cell harvesting takes place afterwards by transferring cells from wells into 2 ml collection tube and centrifuging cells for 5 min at 1,500 rpm at room temperature (<Emphasis Type="Bold">Fig.</Emphasis>
                          <InternalRef RefID="Fig8_2_978-1-60327-527-9">
                            <Emphasis Type="Bold">8.2c</Emphasis>
                          </InternalRef>).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>8.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">Remove supernatant by aspirating carefully (<Emphasis Type="Italic">see</Emphasis>
                          <Emphasis Type="Bold">Note</Emphasis>
                          <Emphasis Type="Bold">2</Emphasis>).</Para>
                      </ItemContent>
                    </ListItem>
                  </OrderedList>
                </Para>
              </Section3>
            </Section2>
            <Section2 ID="Sec8" OutputMedium="Online">
              <Heading>Genomic RNA and DNA</Heading>
              <Para TextBreak="No">Total RNA extraction for each sample is performed following the RNeasy Mini Kit (QIAGEN) instructions (<Emphasis Type="Italic">see</Emphasis>
                <Emphasis Type="Bold">Note</Emphasis>
                <Emphasis Type="Bold">3</Emphasis>): (a) disruption of the cells, (b) washing of the cell lysate, (c) elution of total RNA from disrupted cells. Up to 1 μg of total RNA is synthesized into cDNA through: (a) RNA-oligo (dT) primers pre-heating, b) RT-PCR mixture holding, (c) cDNA synthesis by reverse transcription, (d) RNA clean up.</Para>
              <Section3 ID="Sec9" OutputMedium="Online">
                <Heading>Total RNA Extraction</Heading>
                <Para TextBreak="No">
                  <OrderedList>
                    <ListItem>
                      <ItemNumber>1.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">Add 350 μl of RTL complete lysis buffer (10 μl β-ME per 1 ml RTL buffer; prepare solution before use) in the 2 ml collection tube containing pelleted cells (<Emphasis Type="Italic">see</Emphasis> Section <InternalRef RefID="Sec7">3.1.3</InternalRef>
                          <Emphasis Type="Italic">. and</Emphasis>
                          <Emphasis Type="Bold">Note 4</Emphasis>).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>2.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">Disrupt cells by gently vortexing and then add 350 μl 70% ethanol by mixing.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>3.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">Transfer the lysate into the RNeasy Mini Spin column (maximum loading volume 700 μl) and spin at 16,000 rpm (thereafter referred to as high speed) for 15 s at +4°C. RNA is retained in the white membrane of the RNeasy Mini Spin columns.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>4.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">Discard the flow-through, reuse the collector tube and wash membrane one time with 700 μl RW1 washing buffer (high speed, 15 s at +4°C).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>5.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">Change the collector tube and wash membrane with 500 μl RPI buffer containing four volumes of 96–100% ethanol at high speed for 15 s at +4°C.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>6.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">Discard the flow-through, reuse the collector tube and repeat this wash for 2 min.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>7.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">Discard the collector tube and leave residual ethanol evaporating from the RNeasy Mini Spin column for few seconds.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>8.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">Place RNeasy Mini Spin columns in a new 2 ml collector tube and pipette 25 μl RNAse free water (or DEPC water) in the middle of the membrane of the tube.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>9.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">Spin at high speed for 1 min at +4°C.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>10.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">Repeat the elution with extra 25 μl RNAse free water (same spinning as above).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>11.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">Put RNA eluate on ice, mark it and immediately use it for cDNA synthesis or store it at –70°C until use (<Emphasis Type="Italic">see</Emphasis>
                          <Emphasis Type="Bold">Note</Emphasis>
                          <Emphasis Type="Bold">5</Emphasis>).</Para>
                      </ItemContent>
                    </ListItem>
                  </OrderedList>
                </Para>
              </Section3>
              <Section3 ID="Sec10" OutputMedium="Online">
                <Heading>Complementary DNA (cDNA) Synthesis</Heading>
                <Para TextBreak="No">Each sample of cDNA is synthesized from the corresponding RNA by following four steps:<OrderedList>
                    <ListItem>
                      <ItemNumber>1.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">First, up to 1 μg of total RNA is incubated at 70°C for 10 min with 1 μl oligo (dT) primers (0.5 μg/μl) in a final volume of 12 μl (RNA volume is defined depending on its concentration; adjust with DEPC water to reach the 12 μl final volume).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>2.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">After cooling at 4°C for 1 min, add 7 μl of RT-PCR mix to the sample (2 μl RT buffer 10×, 2 μl 25 mmol MgCl<Subscript>2</Subscript>, 1 μl dNTP 10 mmol, 2 μl 1 M DTT) and hold the mix at 42°C for 5 min.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>3.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">Then, add 1 μl Superscript RT II (50 U/μl) to each sample and synthesize cDNA at 42°C for 50 min and at 70°C for 15 min.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>4.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">Clean up for possible RNA contamination is performed by incubating samples with 1 μl RNase at 37°C for 20 min.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>5.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">Synthesized cDNA should be stored at +4°C (or –20°C for a longer storage)</Para>
                      </ItemContent>
                    </ListItem>
                  </OrderedList>
                </Para>
              </Section3>
            </Section2>
            <Section2 ID="Sec11" OutputMedium="Online">
              <Heading>Quantitative Real-Time PCR Primers and Probe</Heading>
              <Para TextBreak="No">The paragraph includes: (a) Probe labeling for TaqMan method, (b) Primers and probe design, (c) Primers and probe reconstitution.</Para>
              <Section3 ID="Sec12" OutputMedium="Online">
                <Heading>Probe Labeling for TaqMan Method</Heading>
                <Para TextBreak="No">The concept of real-time PCR relies of the detection of PCR products as they accumulate. Current qrt-PCR systems are based on sets of primers and fluorogenic probes. The fluorescence signal increases with each PCR amplification cycle. The PCR cycle in which fluorescence reaches a threshold value of ten times the standard deviation of baseline fluorescence emission is called the cycle threshold (<Emphasis Type="Italic">C</Emphasis>
                  <Subscript>t</Subscript>) and it is inversely proportional to the starting amount of target genetic material <CitationRef CitationID="CR4">(4)</CitationRef>. TaqMan Method indicates a signal generation throught the degradation of a fluorogenic probe by employing the 5’–3?’ nuclease activity of <Emphasis Type="Italic">Taq</Emphasis> DNA polymerase <CitationRef CitationID="CR5">(5)</CitationRef>. TaqMan probes are labeled at the 5’-end with the reporter dye molecule FAM (6-carboxyfluorescein; emission <Emphasis Type="Italic">λ</Emphasis>
                  <Subscript>max</Subscript>=518 nm) and at the 3’-end with the fluorescent quencher dye molecule TAMRA (6-carboxytetramethylrhodamine; emission <Emphasis Type="Italic">λ</Emphasis>
                  <Subscript>max</Subscript>=582 nm) (<Emphasis Type="Italic">see</Emphasis>
                  <Emphasis Type="Bold">Note</Emphasis>
                  <Emphasis Type="Bold">6</Emphasis>).</Para>
              </Section3>
              <Section3 ID="Sec13" OutputMedium="Online">
                <Heading>Primers and Probe Design</Heading>
                <Para TextBreak="No">Cytokine gene primers and probe for qrt-PCR (TaqMan method) are designed by Primer Express software but some guidelines are necessary to reach high quality qrt-PCR performance <CitationRef CitationID="CR2">(2</CitationRef>, <CitationRef CitationID="CR6">6)</CitationRef>.<OrderedList>
                    <ListItem>
                      <ItemNumber>1.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">Primers should be between 15 and 20 nucleotides long and not overlapping with probe complementary sequences in order to cover an amplicon with a length ≤ 150 base pairs (bp). Give prevalence of better probes over primers.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>2.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">Primers melting temperature (<Emphasis Type="Italic">T</Emphasis>
                          <Subscript>m</Subscript>) should be 58–60°C and probes <Emphasis Type="Italic">T</Emphasis>
                          <Subscript>m</Subscript> should be 68–70°C.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>3.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">Primers and probes guanosin/cytosin (G/C) content should be between 20 and 80% (avoiding G to be on the 5’end and having C content higher than G content).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>4.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">To avoid hairpins or loops within primers and probes, the five nucleotides at 3’end of each primer should have no more than two Gs or Cs.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>5.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">Avoid also runs of identical nucleotides within primers.</Para>
                      </ItemContent>
                    </ListItem>
                  </OrderedList>
                </Para>
              </Section3>
              <Section3 ID="Sec14" OutputMedium="Online">
                <Heading>Primers and Probes Reconstitution</Heading>
                <Para TextBreak="No">Primers are usually shipped in a lyophilized state (unless differently requested) while probes are more often shipped in 1× TE solution. The best performance for cytokine gene expression using qrt-PCR assay is achieved by using primers and probes at specific final concentration. In our experience, optimized concentration are: 400 nM for primers (<Emphasis Type="Italic">see</Emphasis>
                  <Emphasis Type="Bold">Note</Emphasis>
                  <Emphasis Type="Bold">7</Emphasis>) and 200 nM for probes <CitationRef CitationID="CR1">(1</CitationRef>, <CitationRef CitationID="CR7">7)</CitationRef>. It is thus suggested to prepare both primers and probes working stock solutions in DEPC water (or 1× TE) at 20 μM for each primer and 12.5 μM for each probe (<Emphasis Type="Italic">see</Emphasis>
                  <Emphasis Type="Bold">Sects. 3.4.1 and 3.4.4</Emphasis>).</Para>
              </Section3>
            </Section2>
            <Section2 ID="Sec15" OutputMedium="Online">
              <Heading>Performing Quantitative Real-Time PCR</Heading>
              <Para TextBreak="No">This paragraph reports indications to precisely perform qrt-PCR for cytokine gene expression analysis: (a) cDNA amplification and quantification (b) tenfold serial dilutions of known gene concentrations for standard curve generation (c) standard curve validation for absolute quantification analysis (<Emphasis Type="Italic">see</Emphasis>
                <Emphasis Type="Bold">Note</Emphasis>
                <Emphasis Type="Bold">8</Emphasis>), (d) TaqMan Master Mix preparation and thermal cycler parameters definition for both standard and test cDNA qrt-PCR reactions.</Para>
              <Section3 ID="Sec16" OutputMedium="Online">
                <Heading>cDNA Amplification and Quantification for Standard Curve Generation</Heading>
                <Para TextBreak="No">Complementary DNA from a positive control template is generated by reverse transcription using a technique identical with the one used for the preparation of test cDNA (<Emphasis Type="Bold">Section 3.2.2</Emphasis>). Cytokine genes are amplified by means of regular PCR using the same primers designed for qrt-PCR (<Emphasis Type="Bold">Section 3.3.2</Emphasis>).<OrderedList>
                    <ListItem>
                      <ItemNumber>1.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">PCR mix: 25 μl HotStart mix (QIAGEN), 1 μl forward primer at 20 μM (400 nM), 1 μl reverse primer at 20 μM (400 nM), 1 μl cDNA, 22 μl DEPC water; final volume 50 μl.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>2.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">PCR parameters:<UnorderedList Mark="Dash">
                            <ItemContent>
                              <Para TextBreak="No">10 min at 95°C</Para>
                            </ItemContent>
                            <ItemContent>
                              <Para TextBreak="No">30 s at 95°C, 30 s at 60°C and 2.5 min at 72°C (40 cycles)</Para>
                            </ItemContent>
                            <ItemContent>
                              <Para TextBreak="No">5 min at 72°C</Para>
                            </ItemContent>
                          </UnorderedList>
                        </Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>3.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">Quantify amplified cDNA (double strand) in μg/ml by spectrophotometry (OD=260).</Para>
                      </ItemContent>
                    </ListItem>
                  </OrderedList>
                </Para>
              </Section3>
              <Section3 ID="Sec17" OutputMedium="Online">
                <Heading>Amplified Gene Serial Dilutions for Standard Curve</Heading>
                <Para TextBreak="No">In order to create a curve by tenfold standard dilutions at known gene concentration, the number of copies of amplified cDNA (standard cDNA) from a positive control template has to be calculated. To perform it you should know:<OrderedList>
                    <ListItem>
                      <ItemNumber>1.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">The concentration of your amplified cDNA (OD260 reading usually in μg/ml)</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>2.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">The molecular weight (MW) of your amplicon</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>3.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">The Avogadro number (number of molecules in 1 mole = 6.023×10<Superscript>23</Superscript>)</Para>
                      </ItemContent>
                    </ListItem>
                  </OrderedList>
                </Para>
                <Para TextBreak="No">Example for calculation of IFNγ molecules after DNA amplification:<OrderedList>
                    <ListItem>
                      <ItemNumber>1.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">OD260 = 461 μg/ml → 4.61 μg/10 μl (4.61 μg → 4.61×10<Superscript>–6</Superscript> g).</Para>
                        <Para TextBreak="No">
                          <Emphasis Type="Italic">This is your starting concentration for serial dilutions (see below).</Emphasis>
                        </Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>2.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">Molecular weight (MW) of IFNγ amplicon = 36,492 g/M</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>3.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">4,61×10<Superscript>–6</Superscript> g/36,492 g/M → 1.26×10<Superscript>–10</Superscript> M</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>4.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">1.26×10<Superscript>–10</Superscript> M * 6.023×10<Superscript>23</Superscript> → 7.61×10<Superscript>13</Superscript> molecules</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>5.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">7.61×10<Superscript>13</Superscript> is equivalent (~) to 1×10<Superscript>14</Superscript> molecules</Para>
                        <Para TextBreak="No">
                          <Emphasis Type="Italic">You have approximately 10</Emphasis>
                          <Superscript>
                            <Emphasis Type="Italic">14</Emphasis>
                          </Superscript>
                          <Emphasis Type="Italic">molecules in 10 μl of your solution.</Emphasis>
                        </Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>6.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">Make tenfold serial dilutions adding 10 μl of your starting solution (10<Superscript>14</Superscript> molecules) to 90 μl DEPC water to reach the final volume of 100 μl. Repeat dilutions as below illustrated (10 μ  sample + 90 μl DEPC water) and stop with the last solution of 10<Superscript>3</Superscript> molecules (<Emphasis Type="Bold">Fig.</Emphasis>
                          <InternalRef RefID="Fig8_3_978-1-60327-527-9">
                            <Emphasis Type="Bold">8.3</Emphasis>
                          </InternalRef>).<Figure Category="Standard" Float="Yes" ID="Fig8_3_978-1-60327-527-9">
                            <Caption Language="En">
                              <CaptionNumber>Fig. 8.3.</CaptionNumber>
                              <CaptionContent>
                                <SimplePara>Serial dilutions preparation.</SimplePara>
                                <SimplePara>Make tenfold serial dilutions adding 10 μl of your starting solution (i.e., 10<Superscript>14</Superscript> molecules) to 90 μl DEPC water to reach the final volume of 100 μl. Repeat dilutions as above illustrated (10 μl  sample + 90 μl DEPC water) and stop with the last solution of 10<Superscript>3</Superscript> molecules. To test your standard for cytokine gene expression, use dilutions from 10<Superscript>8</Superscript> to 10<Superscript>3</Superscript>.</SimplePara>
                              </CaptionContent>
                            </Caption>
                            <MediaObject>
                              <ImageObject Color="BlackWhite" FileRef="MediaObjects/978-1-60327-527-9_8_Fig3_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Linedraw"/>
                            </MediaObject>
                          </Figure>
                        </Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>7.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">Use cDNA serial dilutions for qrt-PCR test or store them at +4°C (or –20°C for a longer storage).</Para>
                      </ItemContent>
                    </ListItem>
                  </OrderedList>
                </Para>
              </Section3>
              <Section3 ID="Sec18" OutputMedium="Online">
                <Heading>Quantitative rt-PCR Reactions</Heading>
                <Para TextBreak="No">Quantitative rt-PCR reactions for both standard and test cDNA are conducted as reported below. To test your standard for cytokine gene expression, use dilutions from 10<Superscript>8</Superscript> to 10<Superscript>3</Superscript>.<OrderedList>
                    <ListItem>
                      <ItemNumber>1.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">Prepare a TaqMan Mix: 12.5 μl of 1× TaqMan Universal Master Mix<Superscript>®</Superscript>, 0.5 μl forward primer at 20 μM (400 nM), 0.5 μl reverse primer at 20 μM (400 nM), 0.4 μl probe at 12.5 μM (200 nM), 10.1 μl DEPC water; final volume 24 μl.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>2.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">Load 96-well optical reaction plate (Applied Biosystems) with 24 μl TaqMan Mix in triplicate for each sample you wish to run. Avoid bubbles.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>3.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">Add cDNA to each of the three wells related to the sample you wish to run.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>4.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">Close tightly the plate.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>5.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">Centrifuge the plate at 2,000 rpm for 2 min at +4°C.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>6.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">Thermal cycler parameters for 25 μl final volume (24  μl TaqMan Mix + 1  μl cDNA) using either an ABI prism 7700, 7900, or 7500FAST Sequence Detection System are:<OrderedList>
                            <ListItem>
                              <ItemNumber>a.</ItemNumber>
                              <ItemContent>
                                <Para TextBreak="No">2 min at 50°C</Para>
                              </ItemContent>
                            </ListItem>
                            <ListItem>
                              <ItemNumber>b.</ItemNumber>
                              <ItemContent>
                                <Para TextBreak="No">10 min at 95°C</Para>
                              </ItemContent>
                            </ListItem>
                            <ListItem>
                              <ItemNumber>c.</ItemNumber>
                              <ItemContent>
                                <Para TextBreak="No">15 s at 95°C (denaturation) and 1 min at 60°C (annealing/extension) for 45 cycles.</Para>
                              </ItemContent>
                            </ListItem>
                          </OrderedList>
                        </Para>
                      </ItemContent>
                    </ListItem>
                  </OrderedList>
                </Para>
              </Section3>
              <Section3 ID="Sec19" OutputMedium="Online">
                <Heading>Standard Curve Validation and Gene Copy Number Extrapolation (Absolute Quantification Method)</Heading>
                <Para TextBreak="No">
                  <OrderedList>
                    <ListItem>
                      <ItemNumber>1.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">Standard curve generation is necessary for the extrapolation of gene copy numbers (absolute quantification of gene copy numbers). Serial dilutions of the amplified gene (standard cDNA) at known concentration (10<Superscript>8</Superscript>–10<Superscript>3</Superscript>) are thus tested by qrt-PCR to determine the standard curve PCR for slope of −3.32, efficiency = 1. It indicates doubling of template after each PCR cycle). Linear regression analysis of each standard should show a high correlation (<Emphasis Type="Italic">R</Emphasis>
                          <Superscript>2</Superscript> ≥ 0.99) (<Emphasis Type="Bold">Fig.</Emphasis>
                          <InternalRef RefID="Fig8_4_978-1-60327-527-9">
                            <Emphasis Type="Bold">8.4</Emphasis>
                          </InternalRef>). Extrapolation of copy number of each given gene (<Emphasis Type="Italic">x</Emphasis>) is conducted following this formula: <Emphasis Type="Italic">x</Emphasis> = 10<Superscript>(unknown sample Ct–<Emphasis Type="Italic">y</Emphasis> intercept)/slope</Superscript>
                          <Figure Category="Standard" Float="Yes" ID="Fig8_4_978-1-60327-527-9">
                            <Caption Language="En">
                              <CaptionNumber>Fig. 8.4.</CaptionNumber>
                              <CaptionContent>
                                <SimplePara>β-Actin standard curve plots for calculation of PCR efficiency and quantitation.</SimplePara>
                                <SimplePara>A tenfold serial dilution of a positive control template is used to generate the standard curve. The resulting threshold cycle (<Emphasis Type="Italic">C</Emphasis>
                                  <Subscript>t</Subscript>) values for each input amount of template are plotted as a function of the log<Subscript>10</Subscript> concentration of input amounts. The resulting slope of the line fitted to the data is used to determine the PCR efficiency. Optimal standard curves are based on PCR amplification efficiency as demonstrated by the slope of the standard curve equation. Linear regression analysis of all standard curves should show a high correlation (<Emphasis Type="Italic">R</Emphasis>
                                  <Superscript>2</Superscript> coefficient ≥0.99) to be considered suitable for gene levels quantitative analysis. The function that defines this slope is also used to calculate the amount of unknown samples. Most real-time PCR instruments have software that can automatically compute the amount of template of an unknown sample from a standard curve. However, it can be done manually by putting the observed <Emphasis Type="Italic">C</Emphasis>
                                  <Subscript>t</Subscript> value for an unknown sample into the following formula: (observed <Emphasis Type="Italic">C</Emphasis>
                                  <Subscript>t</Subscript>–<Emphasis Type="Italic">y</Emphasis> intercept)/slope <CitationRef CitationID="CR1">(1)</CitationRef>.</SimplePara>
                              </CaptionContent>
                            </Caption>
                            <MediaObject>
                              <ImageObject Color="BlackWhite" FileRef="MediaObjects/978-1-60327-527-9_8_Fig4_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Linedraw"/>
                            </MediaObject>
                          </Figure>
                        </Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>2.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">Number of copies of an endogenous control gene (reference gene; i.e., β-actin) is also quantified. For each experimental sample, the value of both target and reference genes are extrapolated from the respective standard curve equation.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>3.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">The target value is divided by the reference gene value to obtain normalized targets (independent from amount of starting material).</Para>
                      </ItemContent>
                    </ListItem>
                  </OrderedList>
                </Para>
              </Section3>
            </Section2>
          </Section1>
          <Section1 ID="Sec20" OutputMedium="Online">
            <Heading>Notes</Heading>
            <Para TextBreak="No">
              <OrderedList>
                <ListItem>
                  <ItemNumber>1.</ItemNumber>
                  <ItemContent>
                    <Para TextBreak="No">Due to differential HLA/peptide binding capacity and cytokine kinetics, incubation time could be extended to 12 h <CitationRef CitationID="CR8">(8)</CitationRef>.</Para>
                  </ItemContent>
                </ListItem>
                <ListItem>
                  <ItemNumber>2.</ItemNumber>
                  <ItemContent>
                    <Para TextBreak="No">To minimize cell handling when working with several samples, a direct centrifugation of the 96-well plate (5 min, 1,250 rpm, 20°C) after 3-h incubation could be performed and the supernatant can be vigorously flicked out.</Para>
                  </ItemContent>
                </ListItem>
                <ListItem>
                  <ItemNumber>3.</ItemNumber>
                  <ItemContent>
                    <Para TextBreak="No">For a higher quality RNA extraction, the RNA extraction Triazol method could be also chosen.</Para>
                  </ItemContent>
                </ListItem>
                <ListItem>
                  <ItemNumber>4.</ItemNumber>
                  <ItemContent>
                    <Para TextBreak="No">RLT complete lysis buffer (RTL + β-ME) can be stored at room temperature for up 1 month. RTL lysis solution (RTL complete lysis buffer + pellet) could be stored at –70°C for months.</Para>
                  </ItemContent>
                </ListItem>
                <ListItem>
                  <ItemNumber>5.</ItemNumber>
                  <ItemContent>
                    <Para TextBreak="No">Due to the instability of RNA at room temperature, all RNA extraction steps and centrifugations should be performed at 0–4°C (ice temperature). Thaw RNA out on ice when it comes from –70°C storage.</Para>
                  </ItemContent>
                </ListItem>
                <ListItem>
                  <ItemNumber>6.</ItemNumber>
                  <ItemContent>
                    <Para TextBreak="No">More reporter dyes are available to label TaqMan probes: TET™, JOE™, VIC™. By using probes labeled with different fluorochromes characterized by unique emission spectra, more genes can be analyzed simultaneously within a given sample (multiplex qrt-PCR) <CitationRef CitationID="CR9">(9)</CitationRef>.</Para>
                  </ItemContent>
                </ListItem>
                <ListItem>
                  <ItemNumber>7.</ItemNumber>
                  <ItemContent>
                    <Para TextBreak="No">Depending on the efficiency of the primers, their optimized concentration should range between 400 and 800 nM</Para>
                  </ItemContent>
                </ListItem>
                <ListItem>
                  <ItemNumber>8.</ItemNumber>
                  <ItemContent>
                    <Para TextBreak="No">As an alternative to absolute quantification method (and more specifically to skip standard curve generation), you can use the relative quantification method (2<Superscript>−</Superscript>
                      <Superscript>Δ</Superscript>
                      <Superscript>Δ</Superscript>
                      <Superscript>
                        <Emphasis Type="Italic">C</Emphasis>
                      </Superscript>
                      <Subscript>t</Subscript>) <CitationRef CitationID="CR10">(10)</CitationRef>
                      <UnorderedList Mark="Dash">
                        <ItemContent>
                          <Para TextBreak="No">Step 1: <Emphasis Type="Italic">C</Emphasis>
                            <Subscript>t</Subscript> target gene (i.e., IFNγ) – <Emphasis Type="Italic">C</Emphasis>
                            <Subscript>t</Subscript> reference gene (i.e., β -actin ) = Δ<Emphasis Type="Italic">C</Emphasis>
                            <Subscript>t</Subscript>.</Para>
                        </ItemContent>
                        <ItemContent>
                          <Para TextBreak="No">Step 2: Δ<Emphasis Type="Italic">C</Emphasis>
                            <Subscript>t</Subscript> peptide stimulation – Δ<Emphasis Type="Italic">C</Emphasis>
                            <Subscript>t</Subscript> no stimulation = ΔΔ<Emphasis Type="Italic">C</Emphasis>
                            <Subscript>t</Subscript>
                          </Para>
                        </ItemContent>
                        <ItemContent>
                          <Para TextBreak="No">Step 3: 2<Superscript>−</Superscript>
                            <Superscript>Δ</Superscript>
                            <Superscript>Δ</Superscript>
                            <Superscript>
                              <Emphasis Type="Italic">C</Emphasis>
                            </Superscript>
                            <Subscript>t</Subscript>
                          </Para>
                        </ItemContent>
                      </UnorderedList>
                    </Para>
                  </ItemContent>
                </ListItem>
              </OrderedList>
            </Para>
            <Para TextBreak="No">This method is used to determine variations among gene expression (relative increase or decrease). For cytokine gene expression measurements upon peptide induction, fold increase of target genes in peptide stimulated cells as compared to baseline gene expression from unstimulated cells can be used <CitationRef CitationID="CR11">(11)</CitationRef>.</Para>
          </Section1>
        </Body>
        <BodyRef FileRef="BodyRef/PDF/978-1-60327-527-9_Chapter_8.pdf" OutputMedium="All" PDFType="Typeset" TargetType="OnlinePDF"/>
        <ChapterBackmatter>
          <Bibliography ID="Bib1">
            <Heading>References</Heading>
            <Citation ID="CR1">
              <CitationNumber>1.</CitationNumber>
              <BibArticle>
                <BibAuthorName>
                  <Initials>M.</Initials>
                  <FamilyName>Provenzano</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>S.</Initials>
                  <FamilyName>Mocellin</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>P.</Initials>
                  <FamilyName>Bonginelli</FamilyName>
                </BibAuthorName>
                <Etal/>
                <Year>2003</Year>
                <ArticleTitle Language="En">Ex vivo screening for immunodominant viral epitopes by quantitative real time polymerase chain reaction (qRT-PCR)</ArticleTitle>
                <JournalTitle>J Transl Med</JournalTitle>
                <VolumeID>1</VolumeID>
                <FirstPage>12</FirstPage>
                <Occurrence Type="DOI">
                  <Handle>10.1186/1479-5876-1-12</Handle>
                </Occurrence>
                <Occurrence Type="PID">
                  <Handle>14675481</Handle>
                </Occurrence>
              </BibArticle>
              <BibUnstructured>Provenzano M, Mocellin S, Bonginelli P, et al. Ex vivo screening for immunodominant viral epitopes by quantitative real time polymerase chain reaction (qRT-PCR). J Transl Med 2003;1:12.</BibUnstructured>
            </Citation>
            <Citation ID="CR2">
              <CitationNumber>2.</CitationNumber>
              <BibArticle>
                <BibAuthorName>
                  <Initials>US.</Initials>
                  <FamilyName>Kammula</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>FM.</Initials>
                  <FamilyName>Marincola</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>SA.</Initials>
                  <FamilyName>Rosenberg</FamilyName>
                </BibAuthorName>
                <Year>2000</Year>
                <ArticleTitle Language="En">Real-time quantitative polymerase chain reaction assessment of immune reactivity in melanoma patients after tumor peptide vaccination</ArticleTitle>
                <JournalTitle>J Natl Cancer Inst</JournalTitle>
                <VolumeID>92</VolumeID>
                <FirstPage>1336</FirstPage>
                <LastPage>44</LastPage>
                <Occurrence Type="COI">
                  <Handle>1:STN:280:DC%2BD3cvjvVCksQ%3D%3D</Handle>
                </Occurrence>
                <Occurrence Type="DOI">
                  <Handle>10.1093/jnci/92.16.1336</Handle>
                </Occurrence>
                <Occurrence Type="PID">
                  <Handle>10944556</Handle>
                </Occurrence>
              </BibArticle>
              <BibUnstructured>Kammula US, Marincola FM, Rosenberg SA. Real-time quantitative polymerase chain reaction assessment of immune reactivity in melanoma patients after tumor peptide vaccination. J Natl Cancer Inst 2000;92:1336–44.</BibUnstructured>
            </Citation>
            <Citation ID="CR3">
              <CitationNumber>3.</CitationNumber>
              <BibArticle>
                <BibAuthorName>
                  <Initials>M.</Initials>
                  <FamilyName>Ghei</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>DF.</Initials>
                  <FamilyName>Stroncek</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>M.</Initials>
                  <FamilyName>Provenzano</FamilyName>
                </BibAuthorName>
                <Year>2005</Year>
                <ArticleTitle Language="En">Analysis of memory T lymphocyte activity following stimulation with overlapping HLA-A*2402, A*0101 and Cw*0402 restricted CMV pp65 peptides</ArticleTitle>
                <JournalTitle>J Transl Med</JournalTitle>
                <VolumeID>3</VolumeID>
                <FirstPage>23</FirstPage>
                <Occurrence Type="DOI">
                  <Handle>10.1186/1479-5876-3-23</Handle>
                </Occurrence>
                <Occurrence Type="PID">
                  <Handle>15916715</Handle>
                </Occurrence>
              </BibArticle>
              <BibUnstructured>Ghei M, Stroncek DF, Provenzano M. Analysis of memory T lymphocyte activity following stimulation with overlapping HLA-A*2402, A*0101 and Cw*0402 restricted CMV pp65 peptides. J Transl Med 2005;3:23.</BibUnstructured>
            </Citation>
            <Citation ID="CR4">
              <CitationNumber>4.</CitationNumber>
              <BibArticle>
                <BibAuthorName>
                  <Initials>M.</Initials>
                  <FamilyName>Provenzano</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>S.</Initials>
                  <FamilyName>Mocellin</FamilyName>
                </BibAuthorName>
                <Year>2007</Year>
                <ArticleTitle Language="En">Complementary techniques: validation of gene expression data by quantitative real time PCR</ArticleTitle>
                <JournalTitle>Adv Exp Med Biol</JournalTitle>
                <VolumeID>593</VolumeID>
                <FirstPage>66</FirstPage>
                <LastPage>73</LastPage>
                <Occurrence Type="DOI">
                  <Handle>10.1007/978-0-387-39978-2_7</Handle>
                </Occurrence>
                <Occurrence Type="PID">
                  <Handle>17265717</Handle>
                </Occurrence>
              </BibArticle>
              <BibUnstructured>Provenzano M, Mocellin S. Complementary techniques: validation of gene expression data by quantitative real time PCR. Adv Exp Med Biol 2007;593:66–73.</BibUnstructured>
            </Citation>
            <Citation ID="CR5">
              <CitationNumber>5.</CitationNumber>
              <BibArticle>
                <BibAuthorName>
                  <Initials>S.</Initials>
                  <FamilyName>Mocellin</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>CR.</Initials>
                  <FamilyName>Rossi</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>P.</Initials>
                  <FamilyName>Pilati</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>D.</Initials>
                  <FamilyName>Nitti</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>FM.</Initials>
                  <FamilyName>Marincola</FamilyName>
                </BibAuthorName>
                <Year>2003</Year>
                <ArticleTitle Language="En">Quantitative real-time PCR: a powerful ally in cancer research</ArticleTitle>
                <JournalTitle>Trends Mol Med</JournalTitle>
                <VolumeID>9</VolumeID>
                <FirstPage>189</FirstPage>
                <LastPage>95</LastPage>
                <Occurrence Type="COI">
                  <Handle>1:CAS:528:DC%2BD3sXjvFWnsr0%3D</Handle>
                </Occurrence>
                <Occurrence Type="DOI">
                  <Handle>10.1016/S1471-4914(03)00047-9</Handle>
                </Occurrence>
                <Occurrence Type="PID">
                  <Handle>12763523</Handle>
                </Occurrence>
              </BibArticle>
              <BibUnstructured>Mocellin S, Rossi CR, Pilati P, Nitti D, Marincola FM. Quantitative real-time PCR: a powerful ally in cancer research. Trends Mol Med 2003;9:189–95.</BibUnstructured>
            </Citation>
            <Citation ID="CR6">
              <CitationNumber>6.</CitationNumber>
              <BibArticle>
                <BibAuthorName>
                  <Initials>S.</Initials>
                  <FamilyName>Mocellin</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>M.</Initials>
                  <FamilyName>Provenzano</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>CR.</Initials>
                  <FamilyName>Rossi</FamilyName>
                </BibAuthorName>
                <Etal/>
                <Year>2003</Year>
                <ArticleTitle Language="En">Use of quantitative real-time PCR to determine immune cell density and cytokine gene profile in the tumor microenvironment</ArticleTitle>
                <JournalTitle>J Immunol Methods</JournalTitle>
                <VolumeID>280</VolumeID>
                <FirstPage>1</FirstPage>
                <LastPage>11</LastPage>
                <Occurrence Type="COI">
                  <Handle>1:CAS:528:DC%2BD3sXntVygsrk%3D</Handle>
                </Occurrence>
                <Occurrence Type="DOI">
                  <Handle>10.1016/S0022-1759(03)00274-6</Handle>
                </Occurrence>
                <Occurrence Type="PID">
                  <Handle>12972183</Handle>
                </Occurrence>
              </BibArticle>
              <BibUnstructured>Mocellin S, Provenzano M, Rossi CR, et al. Use of quantitative real-time PCR to determine immune cell density and cytokine gene profile in the tumor microenvironment. J Immunol Methods 2003;280:1–11.</BibUnstructured>
            </Citation>
            <Citation ID="CR7">
              <CitationNumber>7.</CitationNumber>
              <BibArticle>
                <BibAuthorName>
                  <Initials>US.</Initials>
                  <FamilyName>Kammula</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>KH.</Initials>
                  <FamilyName>Lee</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>AI.</Initials>
                  <FamilyName>Riker</FamilyName>
                </BibAuthorName>
                <Etal/>
                <Year>1999</Year>
                <ArticleTitle Language="En">Functional analysis of antigen-specific T lymphocytes by serial measurement of gene expression in peripheral blood mononuclear cells and tumor specimens</ArticleTitle>
                <JournalTitle>J Immunol</JournalTitle>
                <VolumeID>163</VolumeID>
                <FirstPage>6867</FirstPage>
                <LastPage>75</LastPage>
                <Occurrence Type="COI">
                  <Handle>1:CAS:528:DyaK1MXotFSht7w%3D</Handle>
                </Occurrence>
                <Occurrence Type="PID">
                  <Handle>10586088</Handle>
                </Occurrence>
              </BibArticle>
              <BibUnstructured>Kammula US, Lee KH, Riker AI, et al. Functional analysis of antigen-specific T lymphocytes by serial measurement of gene expression in peripheral blood mononuclear cells and tumor specimens. J Immunol 1999;163:6867–75.</BibUnstructured>
            </Citation>
            <Citation ID="CR8">
              <CitationNumber>8.</CitationNumber>
              <BibArticle>
                <BibAuthorName>
                  <Initials>JB.</Initials>
                  <FamilyName>Lim</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>M.</Initials>
                  <FamilyName>Provenzano</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>OH.</Initials>
                  <FamilyName>Kwon</FamilyName>
                </BibAuthorName>
                <Etal/>
                <Year>2006</Year>
                <ArticleTitle Language="En">Identification of HLA-A33-restricted CMV pp65 epitopes as common targets for CD8(+) CMV-specific cytotoxic T lymphocytes</ArticleTitle>
                <JournalTitle>Exp Hematol</JournalTitle>
                <VolumeID>34</VolumeID>
                <FirstPage>296</FirstPage>
                <LastPage>307</LastPage>
                <Occurrence Type="COI">
                  <Handle>1:CAS:528:DC%2BD28Xis1Wgt7c%3D</Handle>
                </Occurrence>
                <Occurrence Type="DOI">
                  <Handle>10.1016/j.exphem.2005.12.006</Handle>
                </Occurrence>
                <Occurrence Type="PID">
                  <Handle>16543064</Handle>
                </Occurrence>
              </BibArticle>
              <BibUnstructured>Lim JB, Provenzano M, Kwon OH, et al. Identification of HLA-A33-restricted CMV pp65 epitopes as common targets for CD8(+) CMV-specific cytotoxic T lymphocytes. Exp Hematol 2006;34:296–307.</BibUnstructured>
            </Citation>
            <Citation ID="CR9">
              <CitationNumber>9.</CitationNumber>
              <BibArticle>
                <BibAuthorName>
                  <Initials>CT.</Initials>
                  <FamilyName>Wittwer</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>MG.</Initials>
                  <FamilyName>Herrmann</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>CN.</Initials>
                  <FamilyName>Gundry</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>KS.</Initials>
                  <FamilyName>Elenitoba-Johnson</FamilyName>
                </BibAuthorName>
                <Year>2001</Year>
                <ArticleTitle Language="En">Real-time multiplex PCR assays</ArticleTitle>
                <JournalTitle>Methods</JournalTitle>
                <VolumeID>25</VolumeID>
                <FirstPage>430</FirstPage>
                <LastPage>42</LastPage>
                <Occurrence Type="COI">
                  <Handle>1:CAS:528:DC%2BD38XhtFelt7Y%3D</Handle>
                </Occurrence>
                <Occurrence Type="DOI">
                  <Handle>10.1006/meth.2001.1265</Handle>
                </Occurrence>
                <Occurrence Type="PID">
                  <Handle>11846612</Handle>
                </Occurrence>
              </BibArticle>
              <BibUnstructured>Wittwer CT, Herrmann MG, Gundry CN, Elenitoba-Johnson KS. Real-time multiplex PCR assays. Methods 2001;25:430–42.</BibUnstructured>
            </Citation>
            <Citation ID="CR10">
              <CitationNumber>10.</CitationNumber>
              <BibArticle>
                <BibAuthorName>
                  <Initials>KJ.</Initials>
                  <FamilyName>Livak</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>TD.</Initials>
                  <FamilyName>Schmittgen</FamilyName>
                </BibAuthorName>
                <Year>2001</Year>
                <ArticleTitle Language="En">Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method</ArticleTitle>
                <JournalTitle>Methods</JournalTitle>
                <VolumeID>25</VolumeID>
                <FirstPage>402</FirstPage>
                <LastPage>8</LastPage>
                <Occurrence Type="COI">
                  <Handle>1:CAS:528:DC%2BD38XhtFelt7s%3D</Handle>
                </Occurrence>
                <Occurrence Type="DOI">
                  <Handle>10.1006/meth.2001.1262</Handle>
                </Occurrence>
                <Occurrence Type="PID">
                  <Handle>11846609</Handle>
                </Occurrence>
              </BibArticle>
              <BibUnstructured>Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001;25:402–8.</BibUnstructured>
            </Citation>
            <Citation ID="CR11">
              <CitationNumber>11.</CitationNumber>
              <BibArticle>
                <BibAuthorName>
                  <Initials>M.</Initials>
                  <FamilyName>Provenzano</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>L.</Initials>
                  <FamilyName>Bracci</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>S.</Initials>
                  <FamilyName>Wyler</FamilyName>
                </BibAuthorName>
                <Etal/>
                <Year>2006</Year>
                <ArticleTitle Language="En">Characterization of highly frequent epitope-specific CD45RA+/CCR7+/- T lymphocyte responses against p53-binding domains of the human polyomavirus BK large tumor antigen in HLA-A*0201+ BKV-seropositive donors</ArticleTitle>
                <JournalTitle>J Transl Med</JournalTitle>
                <VolumeID>4</VolumeID>
                <FirstPage>47</FirstPage>
                <Occurrence Type="DOI">
                  <Handle>10.1186/1479-5876-4-47</Handle>
                </Occurrence>
                <Occurrence Type="PID">
                  <Handle>17096832</Handle>
                </Occurrence>
              </BibArticle>
              <BibUnstructured>Provenzano M, Bracci L, Wyler S, et al. Characterization of highly frequent epitope-specific CD45RA+/CCR7+/- T lymphocyte responses against p53-binding domains of the human polyomavirus BK large tumor antigen in HLA-A*0201+ BKV-seropositive donors. J Transl Med 2006;4:47.</BibUnstructured>
            </Citation>
          </Bibliography>
        </ChapterBackmatter>
      </Chapter>
    </Book>
  </Series>
</Publisher>
